NEW YORK (dpa-AFX) – On Wall Street, the willingness to buy is threatening to slacken after the recent course records. In view of the fear of further lockdown measures due to rising corona infections, investors are likely to hold back on Monday.
The broker IG valued the Dow Jones Industrial three quarters of an hour before the start of trading 0.37 percent lower to 30 109 points. Before the weekend, the best-known American stock market index had once again set a historic record with 30,218 points. The market-wide S&P 500 and the technology stocks index Nasdaq Composite were also higher on Friday than ever before.
There was once again price-moving company news from the corona vaccine manufacturers. Curevac’s shares rose by more than three percent in the pre-trading period in New York and are likely to continue their record hunt. The German biotech company wants to apply for approval of its Covid-19 vaccine candidate in the EU and Latin America. The approval-relevant clinical phase III study with up to 30,000 participants is to be initiated by the end of 2020, according to CEO Franz-Werner Haas. Curevac expects the first results after two to three months.
The shares of the oil companies Chevron and Exxon Mobil fell, however, in the face of falling oil prices by one and a half percent respectively.
Otherwise, some analyst comments provided impetus. For example, shares in the lighting specialist Cree lost more than two percent to 91.50 US dollars after the US bank Morgan Stanley raised its target price to 93 dollars, but canceled its buy recommendation
In contrast, the shares of Boeing and Spirit Aerosystems Holdings rose by more than two and almost three percent, respectively, after the major Swiss bank UBS issued a buy recommendation for both aviation securities ./gl/mis
– – .
